Patents by Inventor Ya Ping Hsu

Ya Ping Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240069677
    Abstract: A floating image generation device is disclosed, which includes a light source, an image generation module, and a floating image generation unit. The image generation module is disposed above the light source and includes a shading unit and an image generation unit. The shading unit is capable of changing light transmissivity state. The image generation unit is disposed above the shading unit. The floating image generation unit is disposed above the image generation unit. The light source emits a light passing through the shading unit, the image generation unit, and the floating image generation unit to generate a first floating image when the shading unit is in a first light transmissivity state. The light source emits a light passing through the shading unit, the image generation unit, and the floating image generation unit to generate a second floating image when the shading unit is in a second light transmissivity state.
    Type: Application
    Filed: October 18, 2023
    Publication date: February 29, 2024
    Inventors: CHIH-PING HSU, RAN-SHIOU YOU, YU JEN LAI, YA HAN KO
  • Patent number: 9980967
    Abstract: EGFR mutation (T790M) and cancerous stemness have shown drug resistances in human non-small-cell lung cancer (NSCLC), thus development of novel drugs in overcoming drug resistances in the NSCLC therapy is highly desired. SP101 is a novel gefitinib derivative, which can bind the ATP-binding pocket of EGFR to inhibit its EGFR kinase activity. SP101 can reduce the drug resistances of EGFR mutation (T790M) and cancerous stemness in NSCLC. SP101 induced cancer cell death and apoptosis in the gefitinib-resistant EGFR mutation (T790M) H1975 cells. SP101 inhibited phosphorylated EGFR and its downstream Survivin proteins but conversely induced Caspase 3 activation for apoptosis induction. Moreover, SP101 could decrease Oct4 protein level and reduce Survivin proteins but conversely elicited active Caspase 3 in the xenograft human H1975 lung tumors in nude mice.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: May 29, 2018
    Assignee: National Chiao Tung University
    Inventors: Jui-I Chao, Kuang-Kai Liu, Ya-Ping Hsu
  • Publication number: 20070275587
    Abstract: A gripping mechanism for securing in position a bridge board electrically connecting two circuit boards is disclosed. An electrical connecting portion is installed on both of the circuit boards, for electrical connection with the bridge board which has a terminal at both ends. The gripping mechanism includes a gripping component formed by a metal wire bent and pivotally installed at one end of the electrical connecting portion. The gripping component is rotatable so as to better secure in position the bridge board to the circuit boards after the terminals of the bridge board are respectively inserted into the electrical connecting portions of the circuit boards.
    Type: Application
    Filed: September 18, 2006
    Publication date: November 29, 2007
    Applicant: Inventec Corporation
    Inventors: Lin-Wei Chang, Yung-Chin Hsu, Chi-Kang Hsieh, Ya Ping Hsu